Bill Ackman Pershing Square Capital Management
Bill Ackman is the founder and CEO of Pershing Square Capital Management, a New York–based hedge fund. He employs an activist investing approach, seeking to influence the management and direction of the publicly traded companies in which he invests. Frequently in the public eye, Ackman has been noted for both high-profile successes and controversies, such as his well-known short position in Herbalife.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$190M |
| 2 |
Canadian Pacific Kansas City
CP
|
+$507K |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.85% |
| 2 | Materials | 26.14% |
| 3 | Industrials | 21.54% |
| 4 | Consumer Discretionary | 8.48% |
| 5 | Real Estate | 3.99% |
Similar funds
Bill Ackman's Q3 2014 Portfolio in Review
As of Q3 2014, Bill Ackman held 7 positions worth $13.4B, up 6.6% from $12.6B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Bill Ackman's Q3 2014 filing shows 1 new and 1 increased positions. Its largest new stake was Zoetis: 5,536,862 shares worth $205M.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 39% a quarter earlier, followed by Materials and Industrials.
- Bill Ackman's largest Q3 2014 buy was Zoetis: 5,536,862 shares worth $205M.
- Bill Ackman added most to Canadian Pacific Kansas City in Q3 2014, an estimated $507K increase.
- Bill Ackman's ten largest holdings make up 100% of its $13.4B portfolio in Q3 2014.
- Bill Ackman opened 1 new position and closed 0 in Q3 2014.
- Bill Ackman's portfolio value rose 6.6% quarter-over-quarter to $13.4B.
Based on Pershing Square Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.